| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.142 | 17.645 | 15.141 | 18.965 | 22.847 | 18.763 | 21.971 | 26.048 | 29.963 | 32.217 |
| Total Income - EUR | 14.142 | 17.645 | 15.141 | 18.965 | 22.847 | 18.763 | 21.971 | 26.048 | 29.963 | 32.217 |
| Total Expenses - EUR | 7.543 | 6.666 | 8.772 | 9.676 | 11.529 | 10.281 | 10.292 | 12.384 | 15.195 | 20.242 |
| Gross Profit/Loss - EUR | 6.598 | 10.979 | 6.369 | 9.290 | 11.319 | 8.482 | 11.679 | 13.664 | 14.767 | 11.975 |
| Net Profit/Loss - EUR | 6.174 | 10.450 | 5.914 | 9.100 | 11.090 | 8.304 | 11.486 | 13.409 | 14.468 | 11.076 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pricon - Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.042 | 656 | 470 | 327 | 190 | 708 | 273 | 0 | 0 | 0 |
| Current Assets | 7.437 | 10.273 | 6.203 | 15.755 | 26.588 | 33.915 | 45.153 | 26.120 | 15.782 | 13.002 |
| Inventories | 0 | 45 | 44 | 82 | 61 | 0 | 142 | 0 | 0 | 0 |
| Receivables | 304 | 240 | 1.753 | 362 | 387 | 369 | 547 | 534 | 11.367 | 5.810 |
| Cash | 7.134 | 9.988 | 4.405 | 15.311 | 26.140 | 33.546 | 44.465 | 25.586 | 4.416 | 7.192 |
| Shareholders Funds | 8.415 | 10.503 | 5.967 | 14.957 | 25.758 | 33.574 | 44.315 | 25.417 | 14.517 | 11.126 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 64 | 426 | 706 | 1.125 | 1.020 | 1.049 | 1.111 | 703 | 1.265 | 1.877 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pricon - Med Srl